Latest news from Respira Therapeutics, Inc. on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/respira-therapeutics-announces-collaboration-with-united-therapeutics-to-treat-pulmonary-hypertension/?sc=rsin /articles/respira-therapeutics-announces-collaboration-with-united-therapeutics-to-treat-pulmonary-hypertension/?sc=rsin Wed, 12 Apr 2017 10:05:36 EST Respira Therapeutics, Inc. is developing inhaled prescription pharmaceutical products employing its breakthrough high efficiency, AOS(tm) dry powder inhaler (DPI) technology to deliver drugs to treat pulmonary and other diseases. Respira Therapeutics, Inc.